JIA is the most common chronic inflammatory arthritis in children, affecting approximately 1 in every 1,000 children ...

Juvenile idiopathic arthritis (JIA) is an umbrella term for various inflammatory arthritis diseases that can cause many different symptoms according to the type. It’s also known as juvenile rheumatoid ...

Rheumatoid arthritis (RA) in children is now known as juvenile idiopathic arthritis (JIA). There are several types of JIA, all of which cause joint pain and stiffness. Other symptoms include red or ...

Key opportunities include earlier diagnosis and risk stratification, targeted biologics and oral JAK inhibitors, expanded pediatric indications and access, better specialist referral and care ...

Proper diagnosis and treatment are key when it comes to this autoimmune condition, the most common form of arthritis affecting children and teens. Clearing up misconceptions can help. The term ...

The use of biologic and targeted therapies for children with juvenile idiopathic arthritis (JIA) surpassed more typical therapies in recent years, according to researchers. The use of biologic and ...

Persistent joint pain in children may signal juvenile arthritis, not just growing pains. Early identification of this ...

The American College of Rheumatology (ACR) has released updated guidelines on pharmacologic and nonpharmacologic treatments for juvenile idiopathic arthritis. The American College of Rheumatology (ACR ...

Arthritis is usually associated with older people but kids can suffer too. Juvenile idiopathic arthritis (JIA) is the most common type of arthritis in children. It affects about about 1 in 1,000 kids ...

What drives non-infectious uveitis in children, and how well do current treatments hold up over time? In a Saudi Arabian cohort, juvenile idiopathic arthritis (JIA) emerged as the leading cause, and ...

Relapse occurred in over half of patients with juvenile idiopathic arthritis (JIA) within a year of stopping biologic or targeted synthetic disease-modifying antirheumatic drug (DMARD) treatment after ...

The use of biologic and targeted therapies for children with juvenile idiopathic arthritis (JIA) surpassed more typical therapies in recent years, according to Rutgers Health researchers. According to ...